Improving pressure ulcer care in intensive care units: Evaluating the impact of bundled care and silver nanoparticle dressings

Table 3 Baseline characteristics of control and intervention groups

	Total (n = 98)	Control group (n = 49)	Intervention group (n = 49)	P value
Age (yr)		54 (35.5-68.5)	52 (36.5-69.5)	0.881
Gender
Male	61	29	32
Female	37	20	17	0.677
Stage
Stage I	38	20	18
Stage II	39	21	18
Stage III	12	6	6
Stage IV	2	1	1
Unstageable	7	1	6	0.419
Location
Coccyx	36	20	16
Buttocks	14	8	6
Trochanter	10	5	5
Scapila	8	4	4
Malleolus	8	4	4
Head	5	3	2
Heel	7	3	4
Elbow	10	2	8	0.700
Comorbid conditions
Sepsis	45	24	21	0.685
Myocardial infarction	1	1	0	1.000
Congestive heart failure	29	16	13	0.659
Cerebral vascular disease	2	0	2	0.495
Chronic pulmonary disease	14	8	6	0.774
Diabetes with complication	4	2	2	1.000
Diabetes without complications	20	9	11	0.803
Total braden at ICU admit		14 (10-20)	13 (10.5-18.5)	0.565

ICU: Intensive care unit.